关注
Jessica Ann Finn
Jessica Ann Finn
Senior Scientist, Protein Engineering at Atreca, Inc.
在 atreca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
High frequency of shared clonotypes in human B cell receptor repertoires
C Soto, RG Bombardi, A Branchizio, N Kose, P Matta, AM Sevy, ...
Nature 566 (7744), 398-402, 2019
2902019
A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface
S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ...
Cell 177 (5), 1136-1152. e18, 2019
2082019
Protocols for molecular modeling with Rosetta3 and RosettaScripts
BJ Bender, A Cisneros III, AM Duran, JA Finn, D Fu, AD Lokits, BK Mueller, ...
Biochemistry 55 (34), 4748-4763, 2016
2022016
Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
JJ Mousa, MF Sauer, AM Sevy, JA Finn, JT Bates, G Alvarado, HG King, ...
Proceedings of the National Academy of Sciences 113 (44), E6849-E6858, 2016
482016
Structural diversity of ultralong CDRH3s in seven bovine antibody heavy chains
J Dong, JA Finn, PA Larsen, TPL Smith, JE Crowe Jr
Frontiers in immunology 10, 558, 2019
402019
Tissue-specific expressed antibody variable gene repertoires
BS Briney, JR Willis, JA Finn, BA McKinney, JE Crowe Jr
PLoS One 9 (6), e100839, 2014
402014
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design
CT Schoeder, S Schmitz, J Adolf-Bryfogle, AM Sevy, JA Finn, MF Sauer, ...
Biochemistry 60 (11), 825-846, 2021
372021
Impact of new sequencing technologies on studies of the human B cell repertoire
JA Finn, JE Crowe Jr
Current opinion in immunology 25 (5), 613-618, 2013
332013
Improving loop modeling of the antibody complementarity-determining region 3 using knowledge-based restraints
JA Finn, J Koehler Leman, JR Willis, A Cisneros III, JE Crowe Jr, J Meiler
PloS one 11 (5), e0154811, 2016
302016
Recognition of influenza H3N2 variant virus by human neutralizing antibodies
S Bangaru, T Nieusma, N Kose, NJ Thornburg, JA Finn, BS Kaplan, ...
JCI insight 1 (10), 2016
272016
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization
JR Willis, JA Finn, B Briney, G Sapparapu, V Singh, H King, ...
PNAS, 2016
272016
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
SJ Zost, J Dong, IM Gilchuk, P Gilchuk, NJ Thornburg, S Bangaru, N Kose, ...
The Journal of Clinical Investigation, 2021
262021
PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST
C Soto, JA Finn, JR Willis, SB Day, RS Sinkovits, T Jones, S Schmitz, ...
BMC bioinformatics 21 (1), 1-7, 2020
232020
Identification of structurally related antibodies in antibody sequence databases using rosetta-derived position-specific scoring
JA Finn, J Dong, AM Sevy, E Parrish, I Gilchuk, R Nargi, M Scarlett-Jones, ...
Structure 28 (10), 1124-1130. e5, 2020
102020
Antibodies that bind tumor tissue for diagnosis and therapy
J DeFalco, DE Emerling, J Finn, NM Greenberg, V Huang, SM Lippow, ...
US Patent App. 16/792,115, 2020
12020
Antibodies that bind tumor tissue for diagnosis and therapy
J DeFalco, DE Emerling, J Finn, NM Greenberg, V Huang, SM Lippow, ...
US Patent App. 17/935,152, 2023
2023
Discovery and pre-clinical development of a novel and differentiated EphA2-targeted antibody in multiple bispecific formats
M Bhatti, M Weiss, A Haltom, J Finn, A Gai, A Ye, D Zhang, C Czupalla, ...
Journal for Immunotherapy of Cancer 10, A1238-A1238, 2022
2022
EphA2 antibodies
A Scholz, N Vad, MS Weiss, YE Anne, D Zhang, IT Aydin, MM Bhatti, ...
US Patent App. 17/687,558, 2022
2022
Tissue-Specific Expressed Antibody Variable Gene Repertoires (vol 9, e100839, 2014)
BS Briney, JR Willis, JA Finn, BA McKinney, JE Crowe Jr
PLOS ONE 15 (1), 2020
2020
Correction: Tissue-Specific Expressed Antibody Variable Gene Repertoires
BS Briney, JR Willis, JA Finn, BA McKinney, JE Crowe Jr
Plos one 15 (1), e0228412, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20